Marc Siegel noted that Lillys Zepbound and Mounjaro already target two metabolic pathways GLP-1 and GIP which work together to promote weight loss, reduce hunger and inflammation, improve insulin function and slow digestion
INDEMNIFICATION AGREEMENT: User agrees to defend, indemnify, and hold harmless the Company and its respective directors, officers, employees, agents, suppliers, partners, owners, successors, and assigns from and against any claims, liabilities, damages, judgments, awards, losses, costs, expenses, or fees (including reasonable attorneys fees) arising out of or relating to Users violation of this Agreement and/or those related to any third-party due to or arising out of Users use of the Website
They have not been studied in the clinical trials behind those medications
But thats a whole other story for another article
June 17, 2025: As Mounjaro Lawsuits in U.S